• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

This podcast was originally published on Diagnostic Imaging's sister publication, NeurologyLive.

In an exclusive interview, Scott D. Newsome, D.O., president of the Consortium of Multiple Sclerosis Centers (CMSC), director of Neurosciences Consultation and Infusion Center at Green Spring Station, and associate professor of neurology at Johns Hopkins Medicine, and David Li M.D., FRCPC, professor of radiology, associate member of neurology, and director of Multiple Sclerosis/MRI Research Group at the University of British Columbia, discussed the recent consensus MRI guidelines for multiple sclerosis.

These guidelines were published by the Magnetic Resonance Imaging in Multiple Sclerosis study group, the CMSC working group, and the North America Imaging in Multiple Sclerosis Guidelines working group.

Related Content: New MRI Guidelines for Multiple Sclerosis Show Global Agreement

In particular, these guidelines provided recommendations on using standardized MRI protocols for both diagnostic and prognostic purposes. Previous guidelines were released in 2015 and 2016. They supported using axial single T2-weighted sequences, dual-echo T2-weighted spin-echo sequences, axial and sagittal T2-weighted fluid-attenuated inversion recovery (FLAIR), and contrast-enhanced axial T1-weighted sequences, preferably at 3T.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.